Research Reveals Missed Diagnoses of Maternal HIV During Pregnancy and Its Impact on Newborns
Recent research uncovers significant gaps in detecting maternal HIV infections during pregnancy, risking neonatal health. Emphasizing the need for improved screening and early treatment, especially among high-risk groups, to prevent mother-to-child transmission.
A recent study highlights concerning gaps in detecting maternal HIV infections during pregnancy, risking the health of newborns. Although current guidelines recommend routine HIV testing early in pregnancy, the study found that many cases of maternal HIV go unnoticed, especially when infections occur later in pregnancy. This oversight can prevent timely treatment, increasing the risk of mother-to-child transmission.
The research, which analyzed Medicaid data for over three million infants born between 2009 and 2021, identified that more than half of the infants diagnosed with HIV within their first year did not receive the recommended postnatal antiretroviral prophylaxis. This absence of treatment suggests that the mothers' HIV status was not recognized during pregnancy, missing critical opportunities for intervention. Notably, the majority of untreated HIV-exposed infants were Black, reflecting ongoing racial disparities in healthcare access and maternal care.
Experts emphasize that early diagnosis of maternal HIV is vital. While nearly all infants born to HIV-positive mothers in the U.S. receive preventive treatment today, these findings demonstrate the importance of consistent and repeated HIV screening throughout pregnancy, including retesting in the third trimester to detect new infections. Such measures could significantly reduce the risk of transmitting HIV to the child.
The study sheds light on broader racial disparities, with a higher percentage of untreated HIV exposure in Black infants, in line with national data showing disproportionate HIV prevalence among women of childbearing age, especially Black women. Strengthening prenatal screening and ensuring timely treatment for HIV-positive pregnant women are essential steps in eliminating mother-to-child transmission.
In conclusion, preventing perinatal HIV transmission relies heavily on early and repeated maternal testing, prompt treatment, and addressing disparities in healthcare to protect the health of future generations.
Source: https://medicalxpress.com/news/2025-07-maternal-hiv-infections-pregnancy.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Opioid Testing Methods Promise Enhanced Treatment Strategies
Researchers from Brown University have developed advanced automated testing methods for detecting opioids in small blood samples and dried blood spots, promising significant improvements in opioid diagnosis and treatment, especially for newborns and individuals with opioid use disorder.
Many Medicare Beneficiaries Face Higher Out-of-Pocket Drug Costs Under New Legislation
New analysis reveals that while the Inflation Reduction Act aims to lower drug costs, most Medicare beneficiaries may face higher out-of-pocket expenses due to plan restructuring and increased deductibles. Learn how recent changes impact drug affordability for seniors.
Saliva Testing Equates to Blood Tests for Managing Epilepsy with Keto Diet
A groundbreaking saliva test now matches blood tests in accurately monitoring ketone levels for epilepsy management, offering a painless alternative for children and adults on the ketogenic diet.
Study Highlights Differences Between Treadmill and Outdoor Running Using Wearable Technology
A recent study using wearable sensors reveals significant biomechanical differences between treadmill and outdoor running, offering insights into injury risk and prevention strategies.